May 2003
Br J Cardiol 2003;10:197-205
Thrombolytic therapy for acute ischaemic stroke improves outcome in a highly selected group of patients. It will shortly be licensed in the UK for this
Read More
March 2003
Br J Cardiol (Heart Brain) 2003;10:HB 15–HB 19
Stroke, cognitive impairment and dementia are well-established complications of long-standing hypertension. There is a considerable time lag, usually several decades, between the onset of hypertension
Read More
October 2002
Br J Cardiol 2002;9:530-2
The major objective for the diagnosis and treatment of hypertension should be the detection of those at increased risk of coronary heart disease (CHD) and
Read More
April 2002
Br J Cardiol 2002;9:223-5
It has now become possible to close a patent foramen ovale (PFO) using a percutaneous device. In addition, it has become increasingly clear that right-to-left
Read More
March 2002
Br J Cardiol 2002;9:163-7
Coronary heart disease (CHD) and stroke frequently coexist, partly because they share many risk factors. After myocardial infarction (MI), there is a significant risk of
Read More
February 2002
Br J Cardiol 2002;9:103-5
Defining prognosis may be helpful in planning acute treatment of stroke, setting rehabilitation goals and setting resource priorities. Case fatality is 12% within the first
Read More
January 2002
Br J Cardiol 2002;9:23-30
The devastating consequences of stroke make rehabilitation a substantial challenge. The benefits of stroke units are well established; the collaborative work of the multidisciplinary team
Read More